Guided Therapeutics Inc. (GTHP)
OTC PINK OTC PINK Primary Summary
Guided Therapeutics Inc. (GTHP) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Guided Therapeutics Inc. ever had a stock split?
Guided Therapeutics Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Mark L. Faupel CEO | OTC PINK Exchange | 40171F501 CUSIP |
| US Country | 3 Employees | - Last Dividend | 29 Mar 2019 Last Split | - IPO Date |
Overview
Guided Therapeutics, Inc. is an innovative medical technology company primarily focused on the development and commercialization of non-invasive diagnostic devices. The inception of this company traces back to 1992 under the name SpectRx, Inc., before it underwent a name change to Guided Therapeutics, Inc. in February 2008. Situated in Norcross, Georgia, the company is dedicated to advancing the early detection of diseases through their groundbreaking technologies, with a particular emphasis on the detection of cervical cancer. Their mission is to enhance the quality of care for patients by providing painless, non-invasive, and point-of-care diagnostic solutions.
Products and Services
- LuViva
LuViva is the flagship product of Guided Therapeutics, Inc., representing a cutting-edge approach to the early detection of cervical cancer and its precancerous states. This non-invasive medical device is designed to scan the cervix using specific wavelengths of light, capturing the reflective and fluorescent properties inherent to healthy or diseased cervical tissue. The core benefit of LuViva lies in its ability to provide immediate results without the discomfort or invasiveness of traditional biopsy methods, thereby streamlining the diagnostic process and facilitating early intervention. This tool exemplifies the company's dedication to improving patient outcomes through innovative medical technology.
